Immuron Limited
IMRN
$0.71
-$0.04-5.47%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.83M | 4.76M | 4.73M | 4.51M | 4.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.83M | 4.76M | 4.73M | 4.51M | 4.32M |
| Cost of Revenue | 1.75M | 1.69M | 1.63M | 1.52M | 1.40M |
| Gross Profit | 3.08M | 3.07M | 3.09M | 3.00M | 2.91M |
| SG&A Expenses | 5.06M | 5.08M | 5.13M | 5.12M | 5.12M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -704.10K | -805.00K | -912.20K | -1.22M | -1.53M |
| Total Operating Expenses | 7.91M | 8.02M | 8.19M | 8.13M | 8.10M |
| Operating Income | -3.08M | -3.26M | -3.46M | -3.61M | -3.78M |
| Income Before Tax | -2.99M | -3.17M | -3.37M | -4.10M | -4.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.99 | -3.17 | -3.37 | -4.10 | -4.85 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.99M | -3.17M | -3.37M | -4.10M | -4.85M |
| EBIT | -3.08M | -3.26M | -3.46M | -3.61M | -3.78M |
| EBITDA | -3.05M | -3.23M | -3.43M | -3.58M | -3.75M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 1.01B | 969.25M | 923.75M | 918.32M | 912.90M |
| Average Diluted Shares Outstanding | 1.01B | 969.25M | 923.75M | 918.32M | 912.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |